← Back to headlines
Galapagos NV and Gilead Sciences Announce Deal Related to Ouro Medicines Acquisition
Galapagos NV and Gilead Sciences have entered into an agreement concerning the acquisition of Ouro Medicines, signaling a new development in the pharmaceutical sector.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Capercaillie Mating Season Begins in Latvia
just now
Harvard Economist Ludwig Straub Awarded John Bates Clark Medal
11m ago
The Spanish engineer who monitors the 'heart' of the Orion spacecraft from Houston: 'Four humans have visited a world different from ours, and that is something that affects us all'
12m ago
Artemis II Astronauts Capture Diverse Moon Images During Return Journey
14m ago